<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">39092750</PMID><DateCompleted><Year>2024</Year><Month>08</Month><Day>02</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>23</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2050-4527</ISSN><JournalIssue CitedMedium="Internet"><Volume>12</Volume><Issue>8</Issue><PubDate><Year>2024</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Immunity, inflammation and disease</Title><ISOAbbreviation>Immun Inflamm Dis</ISOAbbreviation></Journal><ArticleTitle>Post-COVID pulmonary injury in K18-hACE2 mice shows persistent neutrophils and neutrophil extracellular trap formation.</ArticleTitle><Pagination><StartPage>e1343</StartPage><MedlinePgn>e1343</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e1343</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1002/iid3.1343</ELocationID><Abstract><AbstractText>The involvement of neutrophils in the lungs during the recovery phase of coronavirus disease 2019 (COVID-19) is not well defined mainly due to the limited accessibility of lung tissues from COVID-19 survivors. The lack of an appropriate small animal model has affected the development of effective therapeutic strategies. We here developed a long COVID mouse model to study changes in neutrophil phenotype and association with lung injury. Our data shows persistent neutrophil recruitment and neutrophil extracellular trap formation in the lungs for up to 30 days post-infection which correlates with lung fibrosis and inflammation.</AbstractText><CopyrightInformation>&#xa9; 2024 The Authors. Immunity, Inflammation and Disease published by John Wiley &amp; Sons Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Giannakopoulos</LastName><ForeName>Stefanos</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Cell and Molecular Biology, John A. Burns School of Medicine, University of Hawai'i at Manoa, Honolulu, Hawaii, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Juwon</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Tropical Medicine, Medical Microbiology, and Pharmacology, John A. Burns School of Medicine, University of Hawai'i at Manoa, Honolulu, Hawaii, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pak</LastName><ForeName>Jin</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Tropical Medicine, Medical Microbiology, and Pharmacology, John A. Burns School of Medicine, University of Hawai'i at Manoa, Honolulu, Hawaii, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tallquist</LastName><ForeName>Michelle D</ForeName><Initials>MD</Initials><AffiliationInfo><Affiliation>Center for Cardiovascular Research, John A. Burns School of Medicine, University of Hawai'i at Manoa, Honolulu, Hawaii, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Verma</LastName><ForeName>Saguna</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0003-4194-8327</Identifier><AffiliationInfo><Affiliation>Department of Tropical Medicine, Medical Microbiology, and Pharmacology, John A. Burns School of Medicine, University of Hawai'i at Manoa, Honolulu, Hawaii, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>U54MD007601</GrantID><Agency>Ola HAWAII</Agency><Country/></Grant><Grant><GrantID>R21 AI140248</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U54 MD007601</GrantID><Acronym>MD</Acronym><Agency>NIMHD NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>RS-2023-00266015</GrantID><Agency>Ministry of Health &amp; Welfare, Republic of Korea</Agency><Country/></Grant><Grant><GrantID>U54 GM138062</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><Agency>Hawaii Community Foundation</Agency><Country/></Grant><Grant><GrantID>R21AI140248</GrantID><Acronym>GF</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016422">Letter</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Immun Inflamm Dis</MedlineTA><NlmUniqueID>101635460</NlmUniqueID><ISSNLinking>2050-4527</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 3.4.17.23</RegistryNumber><NameOfSubstance UI="D000085962">Angiotensin-Converting Enzyme 2</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.17.23</RegistryNumber><NameOfSubstance UI="C000705328">Ace2 protein, mouse</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D065206" MajorTopicYN="Y">Extracellular Traps</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009504" MajorTopicYN="Y">Neutrophils</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="Y">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008168" MajorTopicYN="Y">Lung</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055370" MajorTopicYN="N">Lung Injury</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000085962" MajorTopicYN="N">Angiotensin-Converting Enzyme 2</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020556" MajorTopicYN="N">Neutrophil Infiltration</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011658" MajorTopicYN="N">Pulmonary Fibrosis</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">K18&#x2010;hACE2 mouse model</Keyword><Keyword MajorTopicYN="N">NETs</Keyword><Keyword MajorTopicYN="N">SARS&#x2010;CoV&#x2010;2</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">neutrophils</Keyword><Keyword MajorTopicYN="N">pulmonary fibrosis</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>6</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>3</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>7</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>8</Month><Day>2</Day><Hour>12</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>8</Month><Day>2</Day><Hour>12</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>8</Month><Day>2</Day><Hour>7</Hour><Minute>5</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>8</Month><Day>2</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39092750</ArticleId><ArticleId IdType="pmc">PMC11295082</ArticleId><ArticleId IdType="doi">10.1002/iid3.1343</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Stewart I, Jacob J, George PM, et al. Residual lung abnormalities after COVID&#x2010;19 hospitalization: interim analysis of the UKILD Post&#x2010;COVID&#x2010;19 study. Am J Respir Crit Care Med. 2023;207:693&#x2010;703.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10037479</ArticleId><ArticleId IdType="pubmed">36457159</ArticleId></ArticleIdList></Reference><Reference><Citation>Schultz BM, Acevedo OA, Kalergis AM, Bueno SM. Role of extracellular trap release during bacterial and viral infection. Front Microbiol. 2022;13:798853.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8825568</ArticleId><ArticleId IdType="pubmed">35154050</ArticleId></ArticleIdList></Reference><Reference><Citation>Sorvillo N, Cherpokova D, Martinod K, Wagner DD. Extracellular DNA NET&#x2010;works with dire consequences for health. Circ Res. 2019;125:470&#x2010;488.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6746252</ArticleId><ArticleId IdType="pubmed">31518165</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuo Y, Yalavarthi S, Shi H, et al. Neutrophil extracellular traps in COVID&#x2010;19. JCI Insight. 2020;5(11):e138999.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7308057</ArticleId><ArticleId IdType="pubmed">32329756</ArticleId></ArticleIdList></Reference><Reference><Citation>Middleton EA, He XY, Denorme F, et al. Neutrophil extracellular traps contribute to immunothrombosis in COVID&#x2010;19 acute respiratory distress syndrome. Blood. 2020;136:1169&#x2010;1179.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7472714</ArticleId><ArticleId IdType="pubmed">32597954</ArticleId></ArticleIdList></Reference><Reference><Citation>George PM, Reed A, Desai SR, et al. A persistent neutrophil&#x2010;associated immune signature characterizes post&#x2010;COVID&#x2010;19 pulmonary sequelae. Sci Transl Med. 2022;14:eabo5795.</Citation><ArticleIdList><ArticleId IdType="pubmed">36383686</ArticleId></ArticleIdList></Reference><Reference><Citation>Giannakopoulos S, Strange DP, Jiyarom B, et al. In vitro evidence against productive SARS&#x2010;CoV&#x2010;2 infection of human testicular cells: bystander effects of infection mediate testicular injury. PLoS Pathog. 2023;19:e1011409.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10231791</ArticleId><ArticleId IdType="pubmed">37200377</ArticleId></ArticleIdList></Reference><Reference><Citation>Dinnon 3rd, KH , Leist SR, Okuda K, et al. SARS&#x2010;CoV&#x2010;2 infection produces chronic pulmonary epithelial and immune cell dysfunction with fibrosis in mice. Sci Transl Med. 2022;14:eabo5070.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9273046</ArticleId><ArticleId IdType="pubmed">35857635</ArticleId></ArticleIdList></Reference><Reference><Citation>Giannakopoulos S, Ward MA, Bakse J, et al. SARS&#x2010;CoV&#x2010;2 infection leads to sustained testicular injury and functional impairments in K18 hACE2 mice. bioRxiv. Published online November 01, 2023.</Citation></Reference><Reference><Citation>Leist SR, Dinnon 3rd, KH , Sch&#xe4;fer A, et al. A mouse&#x2010;adapted SARS&#x2010;CoV&#x2010;2 induces acute lung injury and mortality in standard laboratory mice. Cell. 2020;183:1070&#x2010;1085.e12.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7510428</ArticleId><ArticleId IdType="pubmed">33031744</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu S, Yu Y, Qu M, et al. Neutrophil extracellular traps contribute to immunothrombosis formation via the STING pathway in sepsis&#x2010;associated lung injury. Cell Death Discov. 2023;9:315.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10457383</ArticleId><ArticleId IdType="pubmed">37626060</ArticleId></ArticleIdList></Reference><Reference><Citation>de Diego C, Lasierra AB, L&#xf3;pez&#x2010;Vergara L, et al. What is the actual relationship between neutrophil extracellular traps and COVID&#x2010;19 severity? A longitudinal study. Respir Res. 2024;25:48.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10797938</ArticleId><ArticleId IdType="pubmed">38243237</ArticleId></ArticleIdList></Reference><Reference><Citation>Krinsky N, Sizikov S, Nissim S, et al. NETosis induction reflects COVID&#x2010;19 severity and long COVID: insights from a 2&#x2010;center patient cohort study in Israel. J Thromb Haemostasis. 2023;21:2569&#x2010;2584.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10088279</ArticleId><ArticleId IdType="pubmed">37054916</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia G, Labrouche&#x2010;Colomer S, Duvignaud A, et al. Impaired balance between neutrophil extracellular trap formation and degradation by DNases in COVID&#x2010;19 disease. J Transl Med. 2024;22:246.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10919029</ArticleId><ArticleId IdType="pubmed">38454482</ArticleId></ArticleIdList></Reference><Reference><Citation>Dean LS, Devendra G, Jiyarom B, et al. Corrigendum: phenotypic alteration of low&#x2010;density granulocytes in people with pulmonary post&#x2010;acute sequelae of SARS&#x2010;CoV&#x2010;2 infection. Front Immunol. 2023;14:1209624.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10176967</ArticleId><ArticleId IdType="pubmed">37187732</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>